Disclaimer
The stock market is subject to significant volatility and inherent risks. Investing in stocks involves potential losses and is not guaranteed to generate profits. Prices of stocks can fluctuate unpredictably, We do not give any buy/sell tips. This article is for Educational purposes only.
The Identical Brains Studios IPO is creating a buzz among investors as it prepares for its debut on the NSE SME platform. This book-built issue aims to raise ₹19.95 crores through a fresh issue of 36.94 lakh equity shares. Investors can track the Identical Brains IPO subscription status, grey market premium (GMP), allotment details, and more for better investment planning.
The Identical Brains IPO price band is set at ₹51 to ₹54 per share, with a minimum application lot size of 2,000 shares. Retail investors can start with a minimum investment of ₹108,000, while HNIs must invest at least ₹216,000 for two lots. Stay updated with the Identical Brains IPO watch to follow its progress.
The Identical Brains IPO grey market premium (GMP) reflects the market's excitement about this offering. Tracking the Identical Brains IPO GMP can help investors understand its demand before listing.
The Identical Brains IPO allotment is expected to be finalized on December 23, 2024. Investors can check their IPO allotment status on BSE or NSE platforms. Stay informed through IPO watch allotment updates for seamless tracking.
Investors can monitor the Identical Brains IPO subscription status to see how retail, HNI, and institutional segments are responding. This insight can guide your decision-making process and help assess the offering's popularity.
For new investors, IPO stands for Initial Public Offering, a process where a company offers its shares to the public for the first time. Key factors like IPO grey market premium, IPO subscription status, and IPO allotment status BSE play a crucial role in evaluating an IPO's potential.
The Identical Brains IPO is a promising opportunity for investors. Stay updated with its latest developments through trusted platforms, and use tools like IPO watch GMP and Identical Brains IPO allotment status to make informed investment decisions.
.jpg&h=570&w=855&q=100&v=20170226&c=1)
| IPO Date | December 18, 2024 to December 20, 2024 |
|---|---|
| Listing Date | December 26, 2024 |
| Face Value | ₹10 per share |
| Price Band | ₹51 to ₹54 per share |
| Lot Size | 2000 Shares |
| Total Issue Size | 3,694,000 shares (aggregating up to ₹19.95 Cr) |
| Fresh Issue | 3,694,000 shares (aggregating up to ₹19.95 Cr) |
| Issue Type | Book Built Issue IPO |
| Listing At | NSE SME |
| Share holding pre-issue | 10,331,958 |
| Shareholding post issue | 14,025,958 |
| Market Maker portion | 186,000 shares |
| Market Maker | Rikhav Securities |
| IPO Open Date | Wednesday, December 18, 2024 |
|---|---|
| IPO Close Date | Friday, December 20, 2024 |
| Basis of Allotment | Monday, December 23, 2024 |
| Initiation of Refunds | Tuesday, December 24, 2024 |
| The credit of Shares to Demat | Tuesday, December 24, 2024 |
| Listing Date | Thursday, December 26, 2024 |
| Cut-off time for UPI mandate confirmation | 5 PM on December 20, 2024 |
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 2,000 | ₹108,000 |
| Retail (Max) | 1 | 2,000 | ₹108,000 |
| HNI (Min) | 2 | 4,000 | ₹216,000 |
| Investor Category | Shares Offered |
|---|---|
| QIB Shares Offered | Not more than 50% of the Net Issue |
| Retail Shares Offered | Not less than 35% of the Net Issue |
| NII (HNI) Shares Offered | Not less than 15% of the Net Issue |
| Period Ended | 30 Sep 2024 | 31 Mar 2024 | 31 Mar 2023 | 31 Mar 2022 |
|---|---|---|---|---|
| Assets | 2,183.64 | 1,702.39 | 475.50 | 226.38 |
| Revenue | 1,149.62 | 2,026.38 | 808.26 | 390.75 |
| Profit After Tax | 240.54 | 534.65 | 161.28 | 51.01 |
| Net Worth | 1,436.08 | 1,203.62 | 288.51 | 127.23 |
| Reserves and Surplus | 402.89 | 514.82 | 287.51 | 126.23 |
| Total Borrowing | 17.09 | 19.04 | - | - |
| Amount in ₹ Lakhs | ||||
The Identical Brains Studios IPO offers a compelling investment opportunity, combining a well-priced issue with strong market interest. By staying informed about key aspects such as the Identical Brains IPO grey market premium (GMP), IPO subscription status, and IPO allotment status, investors can make strategic decisions. With its scheduled listing on the NSE SME platform, the Identical Brains IPO is set to attract significant attention from retail and HNI investors alike. Don’t miss the updates on IPO watch, and track the IPO allotment status BSE to ensure a seamless investment journey.
